DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹498 Cr | ₹572 Cr | ₹523 Cr | ₹407 Cr | ₹335 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DIVIS LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹498 Cr |
Mar2024 | ₹572 Cr |
Mar2023 | ₹523 Cr |
Mar2022 | ₹407 Cr |
Mar2021 | ₹335 Cr |
How is Deferred Tax Assets / Liabilities of DIVIS LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹498 Cr | -12.94 | |
Mar2024 | ₹572 Cr | 9.37 | |
Mar2023 | ₹523 Cr | 28.52 | |
Mar2022 | ₹407 Cr | 21.53 | |
Mar2021 | ₹335 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹161,746.6 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics | |
MANKIND PHARMA | ₹107,160.0 Cr | 3% | 6.2% | 7.5% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 2.4% |
3.2% |
11.9% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses